Events & Presentations | Apellis Pharmaceuticals, Inc.

Loading...

Investors & Media

Events & Presentations

Upcoming Events

Presentations

Documents	Date
Add Files Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration With Pegcetacoplan: Updates on the Randomized Phase 3 DERBY and OAKS Trials	November 12, 2021
Add Files Third Quarter 2021 Earnings Presentation	November 8, 2021
Add Files Efficacy of intravitreal pegcetacoplan in geographic atrophy: results from the DERBY and OAKS trials	October 11, 2021
Add Files Safety of intravitreal pegcetacoplan in geographic atrophy: results from the DERBY and OAKS trials	October 11, 2021
Add Files Safety of intravitreal pegcetacoplan in geographic atrophy: results from the DERBY and OAKS trials	September 30, 2021
Add Files Efficacy of intravitreal pegcetacoplan in geographic atrophy: results from the DERBY and OAKS trials	September 30, 2021
Add Files Apellis DERBY and OAKS Phase 3 Top-Line Results Conference Call Presentation	September 9, 2021
Add Files Second Quarter 2021 Earnings Presentation	August 9, 2021
Add Files Apellis R&D Day Presentation	June 30, 2021
Add Files Apellis EMPAVELI FDA Approval Conference Call Presentation	May 17, 2021
Add Files First Quarter 2021 Earnings Presentation	April 28, 2021
Add Files Pegcetacoplan: Advancing the First Potential Treatment for Geographic Atrophy (GA) Presentation	January 28, 2021
Add Files 39th Annual J.P. Morgan Healthcare Conference Presentation	January 12, 2021
Add Files Jefferies Virtual London Healthcare Conference Call Presentation	November 19, 2020
Add Files COVID-19 Study Updates	October 15, 2020
Add Files PEGASUS Phase 3 Top-Line Results Conference Call Presentation	January 7, 2020

Past Events

Print Page Email Alerts RSS Feeds Contact IR